Figure 4

Sputum eosinophils (%) 24 h after inhaled allergen exposure during the different treatments arms (placebo, mometasone 400 μg, mometasone 800 μg and budesonide 800 μg daily).
Sputum eosinophils (%) 24 h after inhaled allergen exposure during the different treatments arms (placebo, mometasone 400 μg, mometasone 800 μg and budesonide 800 μg daily).